Terns Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing a portfolio of small molecule product candidates to address serious diseases, including oncology, obesity, and non alcoholic steatohepatitis (NASH). Terns programs are based on mechanisms of action that have achieved…